If you couldn’t picture a better way of life than family dairy farming, here’s your chance to prove it. Boehringer Ingelheim Vetmedica, Inc., a family-owned business, is proud to introduce the Dairy Life Photo Contest. The contest is calling all dairy farm families to submit photos that capture what their cherished lifestyle is all about. Winning entrants will appear in a 2012 calendar to be distributed across the country and at the 2011 World Dairy Expo.
Dairy Life Photo Contest submissions should involve any aspect of your dairy operation, along with the family members who make it their life’s work. The only requirement is to make it interesting. Perhaps it will be your daughter’s first time on the halter of her spring calf or dad and grandpa helping with a herd check on a cold winter’s day; whatever it may be, each photo should display the essence of family farming. Each entry should include a story, in 200 words or fewer, about your family, your operation and how your photo depicts this great way of life.
To enter, visit www.bidairyphotos.com, upload your photo, and share your short story. The final entry deadline is May 31, 2011. Winners will be contacted by email prior to August 1. Entries will be judged on the appeal of the photo, as well as the accompanying written story. Entrants must allow photos and stories to be used in the calendar and for publicity uses related to the contest. Only one entry is allowed per family dairy operation.
Boehringer Ingelheim Vetmedica is the business behind a trusted line of products for dairy producers including ToDAY® and ToMORROW® tubes; Pyramid®, Express® FP and Triangle® vaccines; and Cydectin® pour-on.
Boehringer Ingelheim Vetmedica, Inc. (St. Joseph, Mo.) is a subsidiary of Boehringer Ingelheim Corporation based in Ridgefield, Conn., and a member of the Boehringer Ingelheim group of companies.
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
In 2009, Boehringer Ingelheim posted net sales of U.S. $17.7 billion (12.7 billion euro) while spending 21 percent of net sales in its largest business segment, Prescription Medicines, on research and development.
For more information, please visit: www.bi-vetmedica.com.